PO.PS01.06 · 人群科学
将真实世界可穿戴设备数据整合入乳腺癌风险评估:来自All of Us研究计划的证据
Integrating real-world wearable data into breast cancer risk assessment: Evidence from the All of Us Research Program
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
生活方式和遗传因素是已知的乳腺癌风险促成因素,然而将其与临床数据整合入乳腺癌风险评估仍然有限。传统的自我报告生活方式测量易受回忆偏倚影响,而可穿戴设备可提供体育活动和睡眠行为的客观、连续测量。利用美国国立卫生研究院All of Us研究计划的数据(n=633,540名参与者),我们开展了一项回顾性匹配病例对照研究,以评估客观采集的可穿戴设备数据与乳腺癌风险之间的关联,并建立可扩展的分析框架用于因果和机器学习建模。诊断乳腺癌时年龄≥50岁、且在诊断前五年内至少有五个有效周(每周两天或以上)Fitbit数据的女性(n=154),每人按出生日期(±1年)及在同一时间窗内可穿戴设备数据的可用性匹配至多20名无癌对照。数值变量采用Wilcoxon符号秩检验分析,分类变量采用卡方分析。病例组的日均步数较低(6766 ± 3040),低于对照组(7248 ± 3266;p=0.011),日均轻度活动和高度活动分钟数也较少(179.8 ± 69.0和13.6 ± 13.7 vs. 190.2 ± 69.3和16.0 ± 16.9;分别为p = 0.043和p < 0.001)。两组间睡眠指标无显著差异,而乳腺癌家族史在病例组中更常见(p < 0.001)。基于这些发现,我们提出一个多模态整合框架,融合可穿戴设备、调查及电子健康记录数据,未来纳入基因组特征和因果推断技术(例如倾向性评分匹配和因果森林),以完善个体化风险评估。可解释的机器学习方法,包括集成模型和时间序列模型,将实现可解释且动态更新的风险预测。本研究证明了在All of Us基础设施内使用真实世界可穿戴设备数据的可行性,并突显了多模态、因果和可解释建模在人群规模上用于精准乳腺癌筛查和预防的转化潜力。
查看英文原文 English abstract
Lifestyle and genetic factors are known contributors to breast cancer risk, yet their integration with clinical data into breast cancer risk assessment remains limited. Traditional, self-reported lifestyle measures are subject to recall bias, whereas wearable devices provide objective, continuous measurements of physical activity and sleep behaviors. Using data from the National Institutes of Health All of Us Research Program (n=633,540 participants), we conducted a retrospective matched case-control study to evaluate the association between objectively captured wearable data and breast cancer risk, and to establish a scalable analytical framework for causal and machine learning modeling. Females diagnosed with breast cancer at age ≥50 years with at least five valid weeks of Fitbit data (two or more days per week) within the five years preceding diagnosis (n=154) were each matched to up to 20 cancer-free controls by date of birth (±1 year) and availability of wearable data within the same time temporal window. Numerical variables were analyzed using Wilcoxon signed-rank tests, and categorical variables via chi-square analysis. Cases exhibited lower average daily steps (6766 ± 3040) compared to controls (7248 ± 3266; p=0.011), as well as fewer daily light active and very active minutes (179.8 ± 69.0 and 13.6 ± 13.7 vs. 190.2 ± 69.3 and 16.0 ± 16.9; p = 0.043 and p < 0.001, respectively). Sleep metrics were not significantly different between groups, while family history of breast cancer was more common among cases (p < 0.001). Building on these findings, we propose a multimodal integrative framework that merges wearable, survey, and electronic health record data, with future incorporation of genomic features and causal inference techniques (e.g., propensity score matching and causal forests) to refine individualized risk estimation. Explainable machine learning approaches, including ensemble and time-series models, will enable interpretable and dynamically updated risk predictions. This study demonstrates the feasibility of using real-world wearable data within the All of Us infrastructure and underscores the translational potential of multimodal, causal, and interpretable modeling for precision breast cancer screening and prevention at a population scale.
利益披露 Disclosure
Y. Weber,
Maze Therapeutics Stock.
A. Ilaty, None..
X. Kuang, None..
E. L. Nguyen, None..
A. Plaza-Florido, None..
S. Radom-Aizik, None..
A. Ziogas, None..
A. M. Rahmani, None.
H. L. Park,
Illumina Stock.
Novo Nordisk Stock.
Merck Stock.
Organon Stock.